Candidiasis: all 270 studies

Page 1 of 3. Open to participants first (20), then studies with results posted, then the rest; newest registration first within each.

• Large Algorithm Setting and Validation StudyRecruitingNCT07607470
• Prospective Clinical Study, Using a Medical Device (RepHegyn) as an Adjuvant in the Treatment of Fungal (Candidiasis) and Bacterial InfectionsNot yet recruitingNCT07367295
• One-stage Exchange in Candida Periprosthetic Infection a Suitable Way to goRecruitingNCT07303101
• Biofilm Formation and Antifungal Resistance in Candida SpeciesNot yet recruitingNCT07245563
• Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/VulvovaginitisRecruitingNCT06835361Phase 2/3
• Effect of a Multi-strain Probiotic on Recurrent Vulvovaginal CandidiasisRecruitingNCT06480604Not applicable
• Vaginal Ecosystem and Network in the United States StudyEnrolling by invitationNCT06472765
• Invasive Candidiasis in Critical CareRecruitingNCT06456151
• Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal InfectionNot yet recruitingNCT06450990Phase 1/2
• Epidemiological Study of Vulvovaginal Candidiases Strain Types and Risk Factors Among Gynecological Outpatients in ChinaNot yet recruitingNCT06200389
• Use of Maqui Berry Extract in Treating Oral Candidiasis in Diabetes Mellitus Patients and Systemically Healthy PersonsRecruitingNCT05916729Phase 4
• Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant OutcomesRecruitingNCT05908682
• Oropharyngeal Candidiasis (OPC) and S-ECCRecruitingNCT05761197
• The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis SymptomsRecruitingNCT05367089Phase 3
• Efficacy of the Vacucis Candida® AutovaccineNot yet recruitingNCT05289375Not applicable
• PTX3-targeted Antifungal ProphylaxisRecruitingNCT03828773Not applicable
• Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell TransplantsRecruitingNCT03717623Phase 4
• ECMM Candida Registry - CandiRegRecruitingNCT03450005
• CelAgace™ OraRinse Solution for Treatment of CandidiasisNot yet recruitingNCT03250923Phase 1/2
• Use of 405nm Blue Light Emitting Diode in the Treatment of Women With Vulvovaginal Candidiasis: a Clinical TrialRecruitingNCT03075046Not applicable
• Pharmacokinetic Study in Healthy Lactating Women Exposed to IbrexafungerpCompletedNCT06954493Phase 1Results posted
• Ibrexafungerp for the Treatment of Complicated Vulvovaginal CandidiasisCompletedNCT05399641Phase 3Results posted
• An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida AurisCompletedNCT04148287Phase 2Results posted
• Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)CompletedNCT04029116Phase 3Results posted
• Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal CandidiasisCompletedNCT03987620Phase 3Results posted
• Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast InfectionsCompletedNCT03840616Phase 3Results posted
• Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303)CompletedNCT03734991Phase 3Results posted
• Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive CandidiasisCompletedNCT03667690Phase 3Results posted
• Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With CandidaCompletedNCT03630770Phase 1Results posted
• Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)CompletedNCT03363841Phase 3Results posted
• Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal CandidiasisCompletedNCT03253094Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal TreatmentCompletedNCT03059992Phase 3Results posted
• Women's Improvement of Sexual Health (WISH) Demonstration ProjectCompletedNCT03045809Results posted
• Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)CompletedNCT02971007Phase 2Results posted
• Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal InfectionsCompletedNCT02860845Phase 4Results posted
• CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging ExtensionCompletedNCT02734862Phase 2Results posted
• Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy VolunteersCompletedNCT02631954Phase 1Results posted
• CAMB/MAT2203 in Patients With Mucocutaneous CandidiasisCompletedNCT02629419Phase 2Results posted
• A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)CompletedNCT02267382Phase 2Results posted
• Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive CandidiasisCompletedNCT02244606Phase 2Results posted
• Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal CandidiasisCompletedNCT02180828Phase 4Results posted
• Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal CandidiasisCompletedNCT02180100Phase 4Results posted
• Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)TerminatedNCT01945281Phase 2Results posted
• Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal CandidiasisCompletedNCT01926028Phase 1/2Results posted
• A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection)CompletedNCT01891331Phase 2Results posted
• The Study Of Fluconazole For Vulvovaginal CandidiasisCompletedNCT01806623Phase 3Results posted
• An Efficacy and Safety Study of Miconazole and Hydrocortisone Cream in the Treatment of Vulvar CandidiasisCompletedNCT01769339Phase 4Results posted
• Invasive Candidiasis in Saudi ICUsCompletedNCT01490684Results posted
• Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 VaccineCompletedNCT01447407Phase 1Results posted
• Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal CandidiasisCompletedNCT01427738Phase 3Results posted
• Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative WomenCompletedNCT01230814Phase 2Results posted
• Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With EchinocandinsTerminatedNCT01213823Results posted
• Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United KingdomCompletedNCT01202253Results posted
• A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive CandidiasisTerminatedNCT01176058Phase 3Results posted
• A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)CompletedNCT01165320Phase 2Results posted
• Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) TreatmentCompletedNCT01144286Phase 2Results posted
• A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric PatientsTerminatedNCT01092832Phase 3Results posted
• Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067)TerminatedNCT01045798Phase 2Results posted
• A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% FormulationsCompletedNCT01039584Not applicableResults posted
• Monthly Itraconazole Versus Classic Homeopathy for Treatment of Recurrent Vulvovaginal Candidiasis (RVVC)CompletedNCT00895453Not applicableResults posted
• Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal CandidiasisTerminatedNCT00815516Phase 3Results posted
• An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune SystemTerminatedNCT00806351Phase 3Results posted
• An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To CandidaTerminatedNCT00805740Phase 3Results posted
• Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal CandidiasisCompletedNCT00803738Not applicableResults posted
• Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IVCompletedNCT00802854Results posted
• A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal InfectionCompletedNCT00784368Phase 3Results posted
• Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive CandidiasisCompletedNCT00761267Phase 3Results posted
• Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal InfectionCompletedNCT00739934Phase 2Results posted
• Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams BirthweightCompletedNCT00734539Phase 3Results posted
• Anidulafungin Candidemia/Invasive Candidiasis Intensive Care StudyCompletedNCT00689338Phase 3Results posted
• β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) PatientsCompletedNCT00672841Not applicableResults posted
• A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)CompletedNCT00635648Phase 3Results posted
• This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive CandidiasisCompletedNCT00548262Phase 4Results posted
• Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)CompletedNCT00520234Phase 4Results posted
• Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive CandidiasisCompletedNCT00496197Phase 4Results posted
• Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida InfectionsCompletedNCT00413218Phase 3Results posted
• Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV PatientsCompletedNCT00390780Phase 3Results posted
• A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)CompletedNCT00250432Phase 3Results posted
• Efficacy of 5% Nanochitosan Paste in the Treatment of Oral CandidosisCompletedNCT07793331Phase 2
• Diagnostic Performance of the CandID PLUS PCR for the Diagnosis of Intra-abdominal Candidiasis in Critically Ill PatientsCompletedNCT07005258
• Analysis of Candida-Associated Osteoarticular Infections: Multicenter Turkish DataCompletedNCT06788782
• Non-ablative Er:YAG for Recurrent CandidiasisCompletedNCT06572488Not applicable
• Safety and Tolerability Studies of CanProFem-AK, Vaginal Suppositories in Healthy VolunteersCompletedNCT06535126Phase 1
• Efficacy and Safety of Natamycin and Lactulose Vaginal Suppositories in Treatment of Vulvovaginal CandidiasisCompletedNCT06411314Phase 3
• Clinical Study to Evaluate the Efficacy of an Anti-Fungal SupplementCompletedNCT06146504Not applicable
• Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal CandidiasisCompletedNCT06120816Phase 1
• Genital Hygiene Training Provided to Turkish WomenCompletedNCT05998668Not applicable
• Efficacy of Prophylactic Fluconazole Therapy in Preterm and Very Low Birth Weight Neonates in Preventing Invasive Fungal Infection.CompletedNCT05848492Phase 3
• Blue Light Emitting Diode Therapy on Vulvovaginal CandidiasisCompletedNCT05795491Not applicable
• Research of New Serological Markers for the Diagnosis and Monitoring of Candidaemia in Hospitalized PatientsCompletedNCT05720728
• A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive AspergillusCompletedNCT05707832Phase 3
• Prospective Observational Study on the Incidence of Opportunistic Fungal InfectionsCompletedNCT05707156
• Multi-Gyn FloraFem Study for Treatment of Vulvo Vaginal Candidiasis SymptomsCompletedNCT05552378Not applicable
• Evaluate Bioequivalence of Micafungin (50mg/Vial)CompletedNCT05496725Phase 4
• VVC Sampling Study for Analysis ValidationCompletedNCT05327192
• Early Identification of Candida in Intra-abdominal CandidiasisCompletedNCT05264571
• Implementation of a Minor Ailment Service in Community Pharmacy PracticeCompletedNCT05247333Not applicable
• The Role of Interferon-gamma in Immune Responses to Invasive CandidiasisCompletedNCT05235711
• HIV Indicator Diseases in Hospital and Primary CareStatus unknownNCT05225493
• A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Recurrent Vulvovaginal CandidiasisStatus unknownNCT05074602Phase 3

← Candidiasis overview